JINHAI MEDICAL TECHNOLOGY LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.1 HKD | -2.67% |
|
+15.91% | +114.29% |
| Apr. 26 | Jinhai Medical Technology Swings to Loss in 2023 | MT |
| Apr. 02 | Jinhai Medical Technology Limited Appoints Cheng Yuen as Company Secretary | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 419.6 | 380.4 | 289.2 | 595.9 | 460 | 519.7 |
| Enterprise Value (EV) 1 | 400.4 | 368.4 | 268.8 | 573.5 | 438.4 | 499.7 |
| P/E ratio | -119 x | -555 x | 229 x | -2,817 x | 984 x | -159 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 8.84 x | 7.33 x | 12.9 x | 27.8 x | 20.6 x | 11.4 x |
| EV / Revenue | 8.44 x | 7.1 x | 12 x | 26.8 x | 19.7 x | 10.9 x |
| EV / EBITDA | -142 x | 116 x | 120 x | 243 x | 123 x | -377 x |
| EV / FCF | 5,164 x | 64 x | 41.9 x | 260 x | 107 x | -227 x |
| FCF Yield | 0.02% | 1.56% | 2.39% | 0.39% | 0.93% | -0.44% |
| Price to Book | 16.9 x | 15.7 x | 11.3 x | 23.4 x | 18.9 x | 13.9 x |
| Nbr of stocks (in thousands) | 1,230,000 | 1,230,000 | 1,230,000 | 1,230,000 | 1,230,000 | 1,292,500 |
| Reference price 2 | 0.3411 | 0.3093 | 0.2351 | 0.4845 | 0.3740 | 0.4021 |
| Announcement Date | 4/29/19 | 4/28/20 | 4/29/21 | 4/28/22 | 4/28/23 | 4/25/24 |
1SGD in Million2SGD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 47.46 | 51.9 | 22.47 | 21.42 | 22.28 | 45.64 |
| EBITDA 1 | -2.828 | 3.17 | 2.244 | 2.36 | 3.571 | -1.325 |
| EBIT 1 | -3.92 | -0.8631 | -1.759 | -1.4 | 0.000417 | -4.594 |
| Operating Margin | -8.26% | -1.66% | -7.83% | -6.54% | 0% | -10.06% |
| Earnings before Tax (EBT) 1 | -3.856 | 0.0855 | 1.426 | -0.0282 | 0.784 | -3.217 |
| Net income 1 | -3.539 | -0.6858 | 1.263 | -0.212 | 0.4681 | -3.141 |
| Net margin | -7.46% | -1.32% | 5.62% | -0.99% | 2.1% | -6.88% |
| EPS 2 | -0.002877 | -0.000557 | 0.001026 | -0.000172 | 0.000380 | -0.002527 |
| Free Cash Flow 1 | 0.0775 | 5.76 | 6.415 | 2.209 | 4.081 | -2.202 |
| FCF margin | 0.16% | 11.1% | 28.55% | 10.32% | 18.32% | -4.82% |
| FCF Conversion (EBITDA) | - | 181.72% | 285.88% | 93.61% | 114.28% | - |
| FCF Conversion (Net income) | - | - | 507.88% | - | 871.88% | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 4/29/19 | 4/28/20 | 4/29/21 | 4/28/22 | 4/28/23 | 4/25/24 |
1SGD in Million2SGD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - |
| Net Cash position 1 | 19.1 | 12 | 20.5 | 22.4 | 21.6 | 20 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - |
| Free Cash Flow 1 | 0.08 | 5.76 | 6.41 | 2.21 | 4.08 | -2.2 |
| ROE (net income / shareholders' equity) | -13% | -2.79% | 5.08% | -1.83% | 0.48% | -13.2% |
| ROA (Net income/ Total Assets) | -6.81% | -1.41% | -2.68% | -2.39% | 0% | -5.6% |
| Assets 1 | 51.95 | 48.6 | -47.13 | 8.854 | 66,869 | 56.06 |
| Book Value Per Share 2 | 0.0200 | 0.0200 | 0.0200 | 0.0200 | 0.0200 | 0.0300 |
| Cash Flow per Share 2 | 0.0100 | 0.0200 | 0.0200 | 0.0100 | 0.0100 | 0.0200 |
| Capex 1 | 0.31 | 0.65 | 0.14 | 0.61 | 1.18 | 1.24 |
| Capex / Sales | 0.65% | 1.25% | 0.61% | 2.83% | 5.29% | 2.71% |
| Announcement Date | 4/29/19 | 4/28/20 | 4/29/21 | 4/28/22 | 4/28/23 | 4/25/24 |
1SGD in Million2SGD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +114.29% | 866M | |
| +18.21% | 68.37B | |
| +1.28% | 43.42B | |
| -13.97% | 5.17B | |
| +2.00% | 2.23B | |
| -25.53% | 1.82B | |
| +4.67% | 1.47B | |
| +0.46% | 1.43B | |
| -27.40% | 1.15B | |
| -15.03% | 1.1B |
- Stock Market
- Equities
- 2225 Stock
- Financials Jinhai Medical Technology Limited